Results 241 to 250 of about 2,555,654 (307)

Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries. [PDF]

Front Pharmacol
Zhang L, Tian Q, Tang Y, Liu H, Chen Y, Wen H, Liu J, Zhang X, Huang R, Luo Z, Geng T, Xie J.   +11 more
europepmc   +1 more source

New anti‐inflammatory and remodelling drugs for unmet clinical needs in severe asthma and chronic obstructive pulmonary disease (COPD)

British Journal of Pharmacology, EarlyView.
There have been several step‐changes in asthma therapy, with the first being the use of inhaled short‐acting β2‐agonists as bronchodilators and the introduction of inhaled corticosteroids (ICS) to reduce airway inflammation. The next revolution was the advent of inhaled combinations of long‐acting bronchodilators together with inhaled corticosteroids ...
Ian M. Adcock
wiley   +1 more source

Correction: BCR::ABL1 tyrosine kinase inhibitors induce ribosome collisions to activate ZAK-dependent ribotoxic stress and apoptosis in chronic myeloid leukemia. [PDF]

Leukemia
Park J, Kim SH, Park J, Park H, Kim H, Kim DW, Lim C.   +6 more
europepmc   +1 more source

Chronic myeloid leukemia: incorporation of recent advances into current treatment algorithms. [PDF]

Blood Cancer J
Haddad FG, Kantarjian H.
europepmc   +1 more source

PABPC1 in Cancer: From a Translational Housekeeper to a Stress‐Responsive Regulatory Hub

Cancer Science, EarlyView.
PABPC1 shifts from a translational housekeeper to a stress‐responsive oncogenic hub via phase separation, PTMs, and non‐coding RNA crosstalk, selectively driving oncogene translation and therapy resistance in cancer. ABSTRACT PABPC1, long recognized as a constitutive translational housekeeper, has emerged as a stress‐responsive translational ...
Cuiwei Zhang, Ye Zhu, Wenbo Long
wiley   +1 more source

Real-life data of patients with chronic myeloid leukemia in Amazonas. [PDF]

BMC Cancer
Abreu RS, Maior KS, Souza IML, Paes JF, Nascimento BEF, Santos RO, Romero NPG, Martins JP, Costa AG, Malheiro A, Martins-Filho OA, Tarragô AM, Passos LNM.   +12 more
europepmc   +1 more source

Refining the boundary between myelodysplastic neoplasm and chronic myelomonocytic leukaemia under World Health Organization 2022 criteria using open‐source data

British Journal of Haematology, EarlyView.
Jiwon Yun, Hyeyoung Lee, Keun Ju Kim, Seung Gyu Yun, Myung‐Hyun Nam, Yunjung Cho   +5 more
wiley   +1 more source

A Novel Plasma Biomarker hsa_circ_0080018 Drives DLBCL Progression via M2 Polarization of Tumor‐Associated Macrophages

Cancer Science, EarlyView.
The proposed mechanistic model in this study. ABSTRACT Noncoding RNAs, including circular RNAs (circRNAs), have been demonstrated to play vital roles in tumorigenesis. Uncovering the functions of circRNAs in tumorigenesis and their underlying regulatory mechanisms may suggest new approaches to the development of novel diagnostic and therapeutic ...
Yanfeng Liu, Yanan Gao, Chuanli Zhao
wiley   +1 more source

Correction to: Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Ann Hematol
Lee S, Kim HJ, Cheong JW, Shin HJ, Kong JH, Sohn SK, Yoon SS, Zang DY, Jung CW, Kim JA, Lee SE, Lee WS, Choi Y, Kim I, Han JJ, Kim MK, Chong SY, Kim DJ, Jo DY, Kim H, Kwak JY, Lee JH, Uhm J, Lee S, Lee MY, Kim DW.   +25 more
europepmc   +1 more source

Patterns of multimodal MRD response and toxicity with blinatumomab and tyrosine kinase inhibitors in Philadelphia‐positive acute B‐lymphoblastic leukaemia

British Journal of Haematology, EarlyView.
Sebastian M. Stolz, Jeremy W. Deuel, Wiebke Rösler, Rahel Schwotzer, Markus G. Manz, Stefan Balabanov, Max J. Rieger   +6 more
wiley   +1 more source